Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain ; volume:16 ; number:1 ; day:6 ; month:11 ; year:2021 ; pages:1-17 ; date:12.2021
Molecular neurodegeneration ; 16, Heft 1 (6.11.2021), 1-17, 12.2021
- Urheber
-
Klein, Hans-Ulrich
Trumpff, Caroline
Yang, Hyun-Sik
Lee, Annie J.
Picard, Martin
Bennett, David A.
Jager, Philip L. De
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-021-00495-8
- URN
-
urn:nbn:de:101:1-2022012020031577260245
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klein, Hans-Ulrich
- Trumpff, Caroline
- Yang, Hyun-Sik
- Lee, Annie J.
- Picard, Martin
- Bennett, David A.
- Jager, Philip L. De
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease
BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease
BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease